Philips Wins $33.7M ARPA-H Award for Robotic Stroke Care
Cambridge, Massachusetts, United States & Amsterdam, Netherlands, Aug 26, 2026 Royal Philips has received an award of up to...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Cambridge, Massachusetts, United States & Amsterdam, Netherlands, Aug 26, 2026 Royal Philips has received an award of up to...
TORONTO, July 16, 2026 SpinaFX Medical Inc. has achieved a significant regulatory milestone with the Medical Device Regulation (MDR)...
MINNEAPOLIS, Minn., July 13, 2026 HistoSonics has achieved a major international regulatory milestone after receiving CE Mark approval for...
AMSTERDAM, Netherlands, May 18, 2026 Royal Philips has introduced SmartIQ, a breakthrough AI-enabled coronary imaging technology developed for its...
MELBOURNE, Australia, and INDIANAPOLIS, May 15, 2026 Telix Pharmaceuticals Limited announced new strategic collaborations with EDAP TMS S.A. and...
